Clinical Trial Update: Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD)

View source ↗

Summary

The NYU Langone Health trial evaluating kappa opioid receptor imaging for post-traumatic stress disorder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Snippet

Sponsor: NYU Langone Health | Conditions: Post-traumatic Stress Disorder (PTSD), Trauma | Status: TERMINATED